Skip to main content
Premium Trial:

Request an Annual Quote

Accuri Raises $5M in Venture Funds for Cytometer Launch

NEW YORK (GenomeWeb News) - Accuri Cytometers has netted $5 million in Series B financing from Baird Venture Partners and Arboretum Ventures, the company said today.
 
Accuri said it will use the money to fund further testing and to propel the full commercial launch of its C6 flow cytometer system.
 
The C6 system is targeted toward labs that require flow cytometry hardware but lack the funds to buy a high-priced instrument. Accuri plans to market the product for under $30,000.
 
The company said the system is currently in beta testing.
 
CEO Jennifer Baird said the funding will "carry Accuri through broader beta testing and position us for full commercial launch next year."
 
Accuri also said that BVP's Pete Shagory and Arboretum's Tim Peterson have joined its board of directors.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.